Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 113
Filter
Add more filters

Complementary Medicines
Country/Region as subject
Publication year range
1.
Brain Res Bull ; 209: 110909, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38402994

ABSTRACT

BACKGROUND: The efficacy of acupuncture at Zusanli (ST36) in alleviating lower-limb pain is widely acknowledged in clinical practice, while its underlying mechanism remains incompletely elucidated. Our previous research had revealed that the prompt analgesia induced by needling-ST36 was accompanied by expression alterations in certain exco-nucleotidases within the sciatic nerve. Building upon this finding, the current work focused on NTPDase1, the primary ecto-nucleotidase in the human body, which converts ATP into AMP. METHODS: A 20-min acupuncture was administered unilaterally at the ST36 on rats with acute ankle arthritis. The pain thresholds of the injured hind paws were determined. Pharmacological interference was carried out by introducing the corresponding reagents to the sciatic nerve. ATP levels around the excised nerve were measured using a luciferase-luciferin assay. Live calcium imaging, utilizing the Fura 2-related-F340/F380 ratio, was conducted on Schwann cells in excised nerves and cultured rat SCs line, RSC96 cells. RESULTS: The analgesic effect induced by needling-ST36 was impaired when preventing ATP degradation via inhibiting NTPDase1 activities with ARL67156 or Ticlopidine. Conversely, increasing NTPDase1 activities with Apyrase duplicated the acupuncture effect. Similarly, preventing the conversion of AMP to adenosine via suppression of NT5E with AMP-CP hindered the acupuncture effect. Unexpectedly, impeded ATP hydrolysis ability and diminished NTPDase1 expression were observed in the treated group. Agonism at P2Y2Rs with ATP, UTP, or INS365 resulted in anti-nociception. Contrarily, antagonism at P2Y2Rs with Suramin or AR-C 118925xx prevented acupuncture analgesia. Immunofluorescent labeling demonstrated that the treated rats expressed more P2Y2Rs that were predominant in Schwann cells. Suppression of Schwann cells by inhibiting ErbB receptors also prevented acupuncture analgesia. Finally, living imaging on the excised nerves or RSC96 cells showed that agonism at P2Y2Rs indeed led to [Ca2+]i rise. CONCLUSION: These findings strongly suggest that the analgesic mechanism of needling-ST36 on the hypersensation in the lower limb partially relies on NTPDase1 activities in the sciatic nerve. In addition to facilitating adenosine signaling in conjunction with NT5E, most importantly, NTPDase1 may provide an appropriate low-level ATP milieu for the activation of P2Y2R in the sciatic nerve, particularly in Schwann cells.


Subject(s)
Acupuncture Analgesia , Acupuncture Therapy , Antigens, CD , Arthritis , Rats , Humans , Animals , Apyrase , Ankle , Pain , Sciatic Nerve/metabolism , Adenosine Triphosphate/metabolism , Analgesics , Adenosine Monophosphate , Adenosine , Acupuncture Points
2.
Protein Expr Purif ; 203: 106215, 2023 03.
Article in English | MEDLINE | ID: mdl-36535546

ABSTRACT

Apyrase from potato (Solanum tuberosum) is a divalent metal ion-dependent enzyme that catalyzes the hydrolysis of nucleoside di- and tri-phosphates with broad substrate specificity. The enzyme is widely used to manipulate nucleotide levels such as in the G protein-coupled receptor (GPCR) field where it is used to deplete guanine nucleotides to stabilize nucleotide-free ternary agonist-GPCR-G protein complexes. Potato apyrase is available commercially as the native enzyme purified from potatoes or as a recombinant protein, but these are prohibitively expensive for some research applications. Here, we report a relatively simple method for the bacterial production of soluble, active potato apyrase. Apyrase has several disulfide bonds, so we co-expressed the enzyme bearing a C-terminal (His)6 tag with the E. coli disulfide isomerase DsbC at low temperature (18 °C) in the oxidizing cytoplasm of E. coli Origami B (DE3). This allowed low level production of soluble apyrase. A two-step purification procedure involving Ni-affinity followed by Cibacron Blue-affinity chromatography yielded highly purified apyrase at a level of ∼0.5 mg per L of bacterial culture. The purified enzyme was functional for ATP hydrolysis in an ATPase assay and for GTP/GDP hydrolysis in a GPCR-G protein coupling assay. This methodology enables the time- and cost-efficient production of recombinant apyrase for various research applications.


Subject(s)
Apyrase , Solanum tuberosum , Apyrase/genetics , Apyrase/chemistry , Escherichia coli/metabolism , GTP-Binding Proteins/chemistry , GTP-Binding Proteins/metabolism , Recombinant Proteins/chemistry , Solanum tuberosum/genetics , Receptors, G-Protein-Coupled/chemistry , Receptors, G-Protein-Coupled/metabolism
3.
Chem Biodivers ; 18(11): e2100604, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34608744

ABSTRACT

Schistosomiasis, a neglected tropical disease caused by Schistosoma species, harms over 250 million people in several countries. The treatment is achieved with only one drug, praziquantel. Cardamonin, a natural chalcone with in vitro schistosomicidal activity, has not been in vivo evaluated against Schistosoma. In this work, we evaluated the in vivo schistosomicidal activities of cardamonin against Schistosoma mansoni worms and conducted enzymatic apyrase inhibition assay, as well as molecular docking analysis of cardamonin against potato apyrase, S. mansoni NTPDase 1 and S. mansoni NTPDase 2. In a mouse model of schistosomiasis, the oral treatment with cardamonin (400 mg/kg) showed efficacy against S. mansoni, decreasing the total worm load in 46.8 % and reducing in 54.5 % the number of eggs in mice. Cardamonin achieved a significant inhibition of the apyrase activity and the three-dimensional structure of the potato apyrase, obtained by homology modeling, showed that cardamonin may interact mainly through hydrogen bonds. Molecular docking studies corroborate with the action of cardamonin in binding and inhibiting both potato apyrase and S. mansoni NTPDases.


Subject(s)
Apyrase/antagonists & inhibitors , Chalcones/pharmacology , Enzyme Inhibitors/pharmacology , Piperaceae/chemistry , Plant Extracts/pharmacology , Schistosoma mansoni/drug effects , Animals , Apyrase/metabolism , Biomphalaria , Chalcones/chemistry , Chalcones/isolation & purification , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/isolation & purification , Female , Mice , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Solanum tuberosum/enzymology
4.
Am J Chin Med ; 49(3): 661-676, 2021.
Article in English | MEDLINE | ID: mdl-33683190

ABSTRACT

Ulcerative Colitis (UC) is a chronic inflammation disease, and the incidence of UC is increasing recently. Both clinical trials and animal experiments show that moxibustion is a complementary and alternative treatment for UC. Previous studies showed that moxibustion can improve UC by regulating the balance of Tregs and Th17 (Sun et al., 2017). Treg cells is one subset of CD4[Formula: see text] T cells that exert the immunosuppressive function. CD39 and CD73, expressed on the surface of Tregs, hydrolyze ATP to AMP and are further involved in the immunosuppressive function of Tregs. In this study, we investigated the effect of moxibustion on CD39[Formula: see text] Tregs and CD73[Formula: see text] Tregs in dextran sulfate sodium (DSS) induced UC mice. The A2a receptor (A2aR), one of the targets of adenosine, was also detected. The results showed that moxibustion could increase the expression of CD39, CD73, and A2aR in colonic tissue and improve the proportion of CD39[Formula: see text] Tregs and CD73[Formula: see text] Tregs in peripheral blood, inguinal draining lymph nodes and spleen in the UC model. Additionally, A2aR agonists enhanced the cell viability of colonic epithelial cells and inhibit the production of cytokines IL-6 and TNF-[Formula: see text] in vitro, which may further influence the pathway of ATP purine signal metabolism and alleviates the gut inflammation of UC mice. Taken together, this study provides supplemental evidence to reveal the immune related mechanism of moxibustion in the treatment of UC.


Subject(s)
5'-Nucleotidase/metabolism , Antigens, CD/metabolism , Apyrase/metabolism , Colitis, Ulcerative/genetics , Colitis, Ulcerative/therapy , Dextran Sulfate/adverse effects , Moxibustion/methods , Receptor, Adenosine A2A/metabolism , Signal Transduction/genetics , Signal Transduction/physiology , Animals , Cell Survival , Colitis, Ulcerative/etiology , Colitis, Ulcerative/metabolism , Colon/cytology , Disease Models, Animal , Epithelial Cells/metabolism , Epithelial Cells/physiology , Interleukin-6/metabolism , Mice , Tumor Necrosis Factor-alpha/metabolism
5.
Parasitol Int ; 83: 102317, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33676013

ABSTRACT

Granulomas are inflammatory tissue responses directed to a set of antigens. Trapped Schistosoma mansoni eggs promote productive granulomas in the tissues, and they are the main damage caused by schistosomiasis. Some S. mansoni antigenic proteins may have a direct involvement in the resolution of the granulomatous response. The ATP diphosphohydrolases isoforms of this parasite are immunogenic, expressed in all phases of the parasite life cycle and secreted by eggs and adult worms. Potato apyrase is a vegetable protein that cross-reactive with parasite ATP diphosphohydrolases isoforms. In this study, the vegetable protein was purified, before being inoculated in C57BL/6 mice that were later infected with cercariae. Sixty days after infection, adult worms were recovered, antibodies and cytokines were measured, and morphological granuloma alterations evaluated. Immunization of the animals induced significant levels of IgG and IgG1 antibodies and IFN-γ, IL-10 and IL-5 cytokines, but not IL-13, suggesting that potato apyrase is an immunoregulatory protein. Supporting this hypothesis, it was found that liver damage associated with schistosomiasis was mitigated, reducing the size of the areas affected by granuloma to 35% and increasing the presence of multinucleated giant cells in this environment. In conclusion, potato apyrase was found to be effective immunomodulatory antigen for murine schistosomiasis.


Subject(s)
Apyrase/chemistry , Giant Cells/drug effects , Rodent Diseases/parasitology , Schistosoma mansoni/physiology , Schistosomiasis mansoni/veterinary , Solanum tuberosum/chemistry , Animals , Female , Mice , Mice, Inbred C57BL , Schistosoma mansoni/drug effects , Schistosomiasis mansoni/parasitology , Solanum tuberosum/enzymology
6.
Leukemia ; 35(1): 107-118, 2021 01.
Article in English | MEDLINE | ID: mdl-32203145

ABSTRACT

Adult T-cell leukemia/lymphoma (ATLL) patients have an extremely poor prognosis, partly due to their immunosuppressive state. The majority of ATLL patients have leukemic cells with phenotype similar to Tregs, prompting suggestions that ATLL cells themselves have immunosuppressive functions. In this study, we detected CD39 expression on ATLL cells, particularly frequent on aggressive subtypes. CD39 and CD73 convert extracellular adenosine triphosphate (ATP) into adenosine, a key player in Tregs' immunosuppression. In vitro culture, both CD39+ ATLL cells and normal Tregs converted rapidly extracellular ATP to AMP, which was disturbed by CD39 inhibitors, and was negated in the CD39 knockout MJ cell line. The proliferation of cocultured CD4+/CD8+ normal T cells was suppressed by CD39+ MJ cells, but not by CD39 knockout MJ cells. Supplemented ATP was exhausted by an EG7-OVA T-cell line with stable CD39 induction, but not by mock. When these cell lines were subcutaneously transplanted into murine flanks, Poly(I:C) peritoneal administration reduced tumor size to 1/3 in mock-transplanted tumors, but not in CD39 induced tumors. Overall, we found that ATLL cells express CD39 at a high rate, and our results suggest that this helps ATLL cells escape antitumor immunity through the extracellular ATPDase-Adenosine cascade. These findings will guide future clinical strategies for ATLL treatment.


Subject(s)
Antigens, CD/genetics , Apyrase/genetics , Gene Expression Regulation, Leukemic , Immune Tolerance/genetics , Immunomodulation/genetics , Leukemia-Lymphoma, Adult T-Cell/genetics , Leukemia-Lymphoma, Adult T-Cell/immunology , Adenosine Triphosphate/metabolism , Animals , Antigens, CD/metabolism , Apyrase/metabolism , Biomarkers , Cell Line, Tumor , Disease Models, Animal , Gene Expression Profiling , Gene Knockdown Techniques , Heterografts , High-Throughput Nucleotide Sequencing , Humans , Immunophenotyping , Leukemia-Lymphoma, Adult T-Cell/diagnosis , Leukemia-Lymphoma, Adult T-Cell/metabolism , Mice , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , T-Lymphocyte Subsets/pathology
7.
Int J Biol Macromol ; 164: 687-693, 2020 Dec 01.
Article in English | MEDLINE | ID: mdl-32663559

ABSTRACT

NTPDases (EC 3.6.1.5) are enzymes belonging to a protein family which have as a common feature the ability to hydrolyze di- and triphosphate nucleotides (ADP and ATP) to monophosphate nucleosides (AMP) in the presence of Ca+2 and Mg+. The potato apyrase has been the first protein of the NTPDase family to be purified. In mammals, these enzymes are involved in physiologic and sick processes as thromboregulation, inflammatory and immunologic responses. In this study, we investigated the in vitro potential of synthetic chalcones on the inhibition of potato apyrase purified from Solanum tuberosum. The protein was purified with high grade purity and its identity was confirmed by electrophoresis, western blot, and LC-MS/MS. Five out of the eight chemically synthetized chalcones analyzed in this study showed significant inhibition of the apyrase activity. The compound with the best rate of inhibition of ATP hydrolytic activity was able to promote 54% inhibition with a concentration of 3.125 µM. Ticlopidine, used as an inhibition drug control, was able to promote inhibitions around 50% of the activity (IC50 = 2.167 µM). Our results with the potato apyrase inhibition with the synthetic chalcones suggest that these compounds may use as potential lead candidates for the treatment of some diseases associated with nucleotides.


Subject(s)
Adenosine Triphosphate/chemistry , Apyrase/antagonists & inhibitors , Chalcones/chemistry , Adenosine Triphosphate/genetics , Amino Acid Sequence/genetics , Antigens, CD/chemistry , Antigens, CD/genetics , Apyrase/chemistry , Apyrase/genetics , Biotechnology , Chalcones/pharmacology , Chromatography, Liquid , Humans , Hydrolysis/drug effects , Protein Engineering , Solanum tuberosum/enzymology , Tandem Mass Spectrometry
8.
Molecules ; 24(18)2019 Sep 12.
Article in English | MEDLINE | ID: mdl-31547324

ABSTRACT

Oxidative stress is one of the primary factors leading to endothelial dysfunction, a major underlying cause of vascular disorders. This study aims to understand the key signalling pathways regulated by sorghum (Shawaya short black 1 variety; characterised to be very high in its antioxidant activity) under oxidative stress in endothelial cells. Human umbilical vein endothelial cells (HUVECs) were pre-treated with non-cytotoxic concentrations of phenolic-rich black sorghum extract (BSE) prior to induction of oxidative stress using hydrogen peroxide (H2O2). Treatment with BSE upregulated the expression of heme oxygenase 1 (HO1) and endothelial nitric oxide synthase (eNOS) and downregulated the levels of NADPH oxidase 4 (NOX4). BSE treatment significantly reduced the expression of pro-inflammatory mediators such as monocyte chemoattractant protein 1 (MCP1) and intracellular adhesion molecule 1 (ICAM1). Results from this study suggest that phenolic-rich BSE may reduce oxidative stress by regulating pro- and antioxidant signalling pathways and the expression of inflammatory mediators linked to endothelial dysfunction under oxidative stress.


Subject(s)
Gene Expression Regulation/drug effects , Inflammation/genetics , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Sorghum/chemistry , Antioxidants/metabolism , Apyrase/genetics , Heme Oxygenase-1/genetics , Human Umbilical Vein Endothelial Cells , Humans , Inflammation/drug therapy , Inflammation Mediators/metabolism , Intercellular Adhesion Molecule-1/genetics , NADPH Oxidase 4/genetics , Nitric Oxide Synthase Type III/genetics , Oxidative Stress/genetics , Phenols/chemistry , Phenols/pharmacology , Plant Extracts/chemistry
9.
J Food Biochem ; 43(8): e12910, 2019 08.
Article in English | MEDLINE | ID: mdl-31368550

ABSTRACT

Type 2 diabetes mellitus is associated with complications such as Alzheimer disease (AD). Tropical eggplant (Solanum gilo, Solanum kumba, and Solanum aethiopicum) fruits have been extensively used for the treatment of different ailments. This study assesses the effect of an eggplant supplemented-diet on purinergic, monoaminergic, and cholinergic enzyme systems in diabetic male rats, besides determining the presence of alkaloids using GC-MS chromatography. Results from this study show that eggplant fruit diet modulates the activities of the enzymes in purinergic, monoaminergic, and cholinergic enzyme systems associated with AD-like symptoms. Solanum kumba-supplemented diet significantly (p < 0.05) reduced enzyme activities better than S. gilo and S. aethiopicum, which could be due to its rich phytochemical constituents. In conclusion, eggplant fruits could serve as a holistic measure in the prevention of diabetes-related complications such as neurodegenerative disease. PRACTICAL APPLICATIONS: The therapeutic management of diabetes fails to holistically address inflammatory response which likely contributes to type 2 diabetes mellitus (T2DM) occurrence by causing insulin resistance; this, in turn, is intensified in the presence of hyperglycemia to promote long-term complications such as neurodegenerative disorders. The health benefit of a tropical eggplant fruit diet inform a nutritional and therapeutic approach for the prevention and treatment of T2DM and its associated complications such as neurodegenerative disorders has been proved. The eggplant fruit-supplemented diet, which is cost-effective with little or no side effect, could substantially increase the antioxidant status and also modulate the activities of neuronal enzymes in a diabetic model with dementia, as well as Alzheimer's-like symptoms. This study, therefore, revealed more of the benefits of tropical eggplant fruits vis-à-vis their management in hyperglycemia-mediated neurodegeneration.


Subject(s)
Acetylcholinesterase/metabolism , Animal Feed/analysis , Antigens, CD/metabolism , Apyrase/metabolism , Diet , Monoamine Oxidase/metabolism , Solanum melongena , Acetylcholinesterase/genetics , Animals , Butyrylcholinesterase/genetics , Butyrylcholinesterase/metabolism , Diabetes Mellitus, Experimental , Gene Expression Regulation/drug effects , Lipid Peroxidation/drug effects , Male , Monoamine Oxidase/genetics , Rats , Rats, Wistar , Sodium-Potassium-Exchanging ATPase/genetics , Sodium-Potassium-Exchanging ATPase/metabolism , Thiobarbituric Acid Reactive Substances
10.
Ann Hematol ; 98(8): 1845-1854, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31154474

ABSTRACT

Primary immune thrombocytopenia is an autoimmune disease, characterized with decreased platelet and increased risk of bleeding. Recent studies have shown the reduction and dysfunction of regulatory T (Treg) cells in ITP patients. CD39 is highly expressed on the surface of Treg cells. It degrades ATP to AMP and CD73 dephosphorylates AMP into adenosine. Then adenosine binds with adenosine receptor and suppresses immune response by activating Treg cells and inhibiting the release of inflammatory cytokines from effector T (Teff) cells. Adenosine receptor has several subtypes and adenosine A2A receptor (A2AR) plays a crucial role especially within lymphocytes. The CD39+ Treg cells and the expression of A2AR showed abnormality in some autoimmune disease. But knowledge of CD39+ Treg cells and A2AR which are crucial in the adenosine immunosuppressive pathway is still limited in ITP. Thirty-one adult patients with newly diagnosed ITP were enrolled in this study. CD39 and A2AR expression was measured by flow cytometry and RT-PCR. The function of CD39 was reflected by the change of ATP concentration detected by CellTiter-Glo Luminescent Cell Viability Assay. CD39 expression within CD4+CD25+ Treg cells in ITP patients was decreased compared to normal controls. After high-dose dexamethasone therapy, response (R) group showed increased CD39 expression within Treg cells while non-response (NR) group did not show any difference in contrast to those before treatment. The expression of A2AR in CD4+CD25- Teff and CD4+CD25+ Treg cells was both lower in ITP patients than that of normal controls. After therapy, CD4+CD25- Teff cells had higher A2AR expression while CD4+CD25+ Treg cells did not show any difference in comparison to that before treatment. The enzymatic activity of CD39 was damaged in ITP patients and improved after high-dose dexamethasone therapy. In ITP, there was not only numerical decrease but also impaired enzymatic activity in CD39+ Treg cells. After high-dose dexamethasone treatment, these two defects could be reversed. Our results also suggested that ITP patients had reduced A2AR expression in both CD4+CD25+ Treg cells and CD4+CD25- Teff cells. CD4+CD25- Teff cells had increased A2AR expression after treatment.


Subject(s)
Apyrase/genetics , Dexamethasone/therapeutic use , Immunosuppressive Agents/therapeutic use , Purpura, Thrombocytopenic, Idiopathic/drug therapy , Receptor, Adenosine A2A/genetics , T-Lymphocytes, Regulatory/drug effects , Adenosine/immunology , Adenosine/metabolism , Adenosine Triphosphate/immunology , Adenosine Triphosphate/metabolism , Adult , Aged , Apyrase/immunology , Case-Control Studies , Female , Gene Expression , Humans , Immunophenotyping , Lymphocyte Count , Male , Middle Aged , Purpura, Thrombocytopenic, Idiopathic/enzymology , Purpura, Thrombocytopenic, Idiopathic/genetics , Purpura, Thrombocytopenic, Idiopathic/immunology , Receptor, Adenosine A2A/immunology , T-Lymphocytes, Cytotoxic/drug effects , T-Lymphocytes, Cytotoxic/enzymology , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes, Regulatory/enzymology , T-Lymphocytes, Regulatory/immunology
11.
Rev Soc Bras Med Trop ; 52: e20180139, 2019 Mar 28.
Article in English | MEDLINE | ID: mdl-30942255

ABSTRACT

INTRODUCTION: High percentages of structural identity and cross-immunoreactivity have been reported between potato apyrase and Schistosoma mansoni ATP diphosphohydrolase (SmATPDases) isoforms, showing the existence of particular epitopes shared between these proteins. METHODS: Potato apyrase was employed using ELISA, western blot, and mouse immunization methods to verify IgE reactivity. RESULTS: Most of the schistosomiasis patient's (75%) serum was seropositive for potato apyrase and this protein was recognized using western blotting, suggesting that parasite and plant proteins share IgE-binding epitopes. C57BL/6 mice immunized with potato apyrase showed increased IgE antibody production. CONCLUSIONS: Potato apyrase and SmATPDases have IgE-binding epitopes.


Subject(s)
Antibodies, Helminth/immunology , Apyrase/immunology , Epitopes/immunology , Immunoglobulin E/immunology , Schistosoma mansoni/immunology , Schistosomiasis mansoni/immunology , Solanum tuberosum/enzymology , Animals , Blotting, Western , Cross Reactions , Enzyme-Linked Immunosorbent Assay , Female , Mice, Inbred C57BL
12.
Int J Biol Macromol ; 131: 691-696, 2019 Jun 15.
Article in English | MEDLINE | ID: mdl-30902720

ABSTRACT

The present manuscript describes a novel bioassay consisting of apyrase and heat shock protein 90 (Hsp90) without additional co-chaperone supplementation; intended for high-throughput screening of anti-cancer drugs and prognosis of stress. In this regard, Hsp90 and adenosine 5'-triphosphate (ATP) mediated firefly luciferase (FLuc) kinetics was investigated using apyrase and FLuc as client proteins. Bioluminescent assay containing Hsp90, ATP, and apyrase led to complete loss of luminescence at 50 °C which indicates the protective role of Hsp90 against thermal denaturation. Similarly, the assay sample comprising Hsp90, ATP, and FLuc showed 2 fold increments in luminescence than their counterparts. Introduction of bovine serum albumin (BSA) to the pre-incubated assay mixture led to an initial rise in the luminescence (28%) in comparison to the sample containing Hsp90, ATP and FLuc. Therefore, FLuc based HTS assays are not suitable for clinical samples which may contain stabilizing agents. However, thermally denatured FLuc and apyrase could not regain their active conformation even when Hsp90 and ATP were introduced in the assay system. This observation justifies the role of Hsp90 to be protective rather than a reparation agent when acts without co-chaperones.


Subject(s)
Adenosine Triphosphate/metabolism , Apyrase/metabolism , HSP90 Heat-Shock Proteins/metabolism , Luciferases, Firefly/metabolism , Enzyme Activation , Kinetics , Molecular Chaperones/metabolism , Protein Binding , Protein Folding , Protein Refolding , Temperature
13.
Rev. Soc. Bras. Med. Trop ; Rev. Soc. Bras. Med. Trop;52: e20180139, 2019. graf
Article in English | LILACS | ID: biblio-1041506

ABSTRACT

Abstract INTRODUCTION: High percentages of structural identity and cross-immunoreactivity have been reported between potato apyrase and Schistosoma mansoni ATP diphosphohydrolase (SmATPDases) isoforms, showing the existence of particular epitopes shared between these proteins. METHODS: Potato apyrase was employed using ELISA, western blot, and mouse immunization methods to verify IgE reactivity. RESULTS: Most of the schistosomiasis patient's (75%) serum was seropositive for potato apyrase and this protein was recognized using western blotting, suggesting that parasite and plant proteins share IgE-binding epitopes. C57BL/6 mice immunized with potato apyrase showed increased IgE antibody production. CONCLUSIONS: Potato apyrase and SmATPDases have IgE-binding epitopes.


Subject(s)
Animals , Female , Apyrase/immunology , Schistosoma mansoni/immunology , Schistosomiasis mansoni/immunology , Solanum tuberosum/enzymology , Immunoglobulin E/immunology , Antibodies, Helminth/immunology , Epitopes/immunology , Enzyme-Linked Immunosorbent Assay , Blotting, Western , Cross Reactions , Mice, Inbred C57BL
14.
Transplant Proc ; 50(5): 1292-1297, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29880349

ABSTRACT

OBJECTIVE: The objective of this study was to investigate the effect of nucleoside triphosphate diphosphohydrolase-1 (NTPDase1) during acute antibody-mediated rejection (AMR). METHODS: NTPDase1 overexpression, NTPDase1 knockout, and wild-type nude mice skin graft models were used to induce acute AMR. NTPDase1 expression in B cells, NTPDase1 messenger RNA expression in skin grafts, extracellular adenosine diphosphate (ADP) concentration, B-cell volume and surface antigens expression, average platelet transport rate, and ultrastructure and apoptosis of skin graft cells were investigated. RESULTS: During acute AMR in nude mice, higher NTPDase1 expression caused lower extracellular ADP concentration, smaller increase in B-cell volume, and major histocompatibility complex II surface antigen expression, suggesting a negative correlation between them; higher NTPDase1 expression also caused slower average platelet transport rate and less severe skin graft injury, suggesting a negative correlation between them. Pretreatment with high-dose exogenous NTPDase1 inhibited platelet activation and protected skin grafts, but it resulted in prolonged bleeding time (by 51.4%) and prolonged coagulation time (by 44.1%). CONCLUSION: An NTPDase1-associated imbalance in extracellular ADP degradation may contribute to B-cell activation, platelet activation, and more severe skin graft injury in nude mice. Pretreatment with high-dose exogenous NTPDase1 effectively protected skin grafts in nude mice at 1 week, but it increased the risk of bleeding.


Subject(s)
Adenosine Diphosphate/metabolism , Adenosine Triphosphate/physiology , Antigens, CD/metabolism , Apyrase/metabolism , B-Lymphocytes/physiology , Graft Rejection/enzymology , Platelet Activation/physiology , Skin Transplantation , Animals , Antigens, CD/genetics , Antigens, CD/pharmacology , Apyrase/genetics , Apyrase/pharmacology , Cell Size , Graft Rejection/immunology , Lymphocyte Activation/physiology , Male , Mice , Mice, Nude , RNA, Messenger/metabolism
15.
Anal Chim Acta ; 1025: 118-123, 2018 Sep 26.
Article in English | MEDLINE | ID: mdl-29801599

ABSTRACT

Ultrasensitive measurements of intracellular ATP (intATP) based on the firefly luciferase reactions are frequently used to enumerate bacterial or mammalian cells. During clinical applications, extracellular ATP (extATP) should be depleted in biological samples since it interferes with intATP and affects the quantification of bacteria. The extATP can be eliminated by ATP-degrading enzymes but complete hydrolysis of extATP remains a challenge for today's commercial enzymes. The catalytic efficiency of ATP-degrading enzymes depends on enzyme characteristics, sample composition and the ability to deplete diphosphates, triphosphates and their complexes generated during the reaction. This phenomenon restricts the usage of bioluminescence-based ATP methods in clinical diagnostics. In light of this, we have developed a recombinant Shigella flexneri apyrase (RSFA) enzyme and analysed its ATP depletion potential with five commercial biochemical sources including potato apyrase, acid phosphatase, alkaline phosphatase, hexokinase and glycerol kinase. The RSFA revealed superior activity by completely eliminating the extracellular ATP and ATP-complexes, even in biological samples like urine and serum. Therefore, our results can potentially unwrap the chemical and bio-analytical applications of ATP-based bioluminescence tests to develop highly sensitive point-of-care diagnostics.


Subject(s)
Adenosine Triphosphate/metabolism , Apyrase/metabolism , Luminescent Measurements/methods , Shigella flexneri/enzymology , Adenosine Monophosphate/metabolism , Biosensing Techniques/methods , Recombinant Proteins/metabolism , Solanum tuberosum/enzymology
16.
Gene ; 651: 9-22, 2018 Apr 20.
Article in English | MEDLINE | ID: mdl-29408309

ABSTRACT

Impaired glucose homoeostasis due to insulin resistance and decrease sensitivity of pancreatic ß-cells is a feature of liver disease and results into hepatogenous diabetes. Decrease expression of CD39 was linked to inflammation and occurrence of diabetes. Therefore, we performed this study to explore the protective effect of pentoxifylline (PTX) and silymarin administration on the ß-cells of the pancreas in a rat model of thioacetamide induced liver cirrhosis. Biochemical, histological and immunohistochemistry studies of the liver and pancreas were performed and provided an evidence on the protective effect of PTX to pancreatic ß-cells compared to silymarin. Also, silymarin induced a significant improvement of liver cirrhosis compared to PTX. In conclusion, the potential protective effect of PTX against ß-cells deterioration could be attributed to increasing pancreatic CD39 expression and the subsequent increase of adenosine.


Subject(s)
Adenosine/metabolism , Antigens, CD/metabolism , Apyrase/metabolism , Liver Cirrhosis, Experimental/drug therapy , Pancreas/drug effects , Pentoxifylline/therapeutic use , Protective Agents/therapeutic use , Silymarin/therapeutic use , Amylases/blood , Animals , Disease Models, Animal , Insulin-Secreting Cells/drug effects , Liver/pathology , Liver Cirrhosis, Experimental/metabolism , Liver Cirrhosis, Experimental/pathology , Liver Function Tests , Male , Pancreas/pathology , Rats , Rats, Wistar , Transforming Growth Factor beta1/metabolism
17.
Immunol Rev ; 276(1): 121-144, 2017 03.
Article in English | MEDLINE | ID: mdl-28258700

ABSTRACT

Cancers are able to grow by subverting immune suppressive pathways, to prevent the malignant cells as being recognized as dangerous or foreign. This mechanism prevents the cancer from being eliminated by the immune system and allows disease to progress from a very early stage to a lethal state. Immunotherapies are newly developing interventions that modify the patient's immune system to fight cancer, by either directly stimulating rejection-type processes or blocking suppressive pathways. Extracellular adenosine generated by the ectonucleotidases CD39 and CD73 is a newly recognized "immune checkpoint mediator" that interferes with anti-tumor immune responses. In this review, we focus on CD39 and CD73 ectoenzymes and encompass aspects of the biochemistry of these molecules as well as detailing the distribution and function on immune cells. Effects of CD39 and CD73 inhibition in preclinical and clinical studies are discussed. Finally, we provide insights into potential clinical application of adenosinergic and other purinergic-targeting therapies and forecast how these might develop in combination with other anti-cancer modalities.


Subject(s)
5'-Nucleotidase/metabolism , Antibodies, Monoclonal/therapeutic use , Antigens, CD/metabolism , Apyrase/metabolism , Immunotherapy/methods , Neoplasms/therapy , 5'-Nucleotidase/immunology , Animals , Antigens, CD/immunology , Apyrase/immunology , Clinical Trials as Topic , Combined Modality Therapy , Drug Evaluation, Preclinical , GPI-Linked Proteins/immunology , GPI-Linked Proteins/metabolism , Humans , Neoplasms/immunology , Tumor Escape , Tumor Microenvironment
18.
Sci Rep ; 7: 44625, 2017 03 16.
Article in English | MEDLINE | ID: mdl-28300164

ABSTRACT

Excessive neutrophilic inflammation contributes to brain pathology and adverse outcome in pneumococcal meningitis (PM). Recently, we identified the NLRP3 inflammasome/interleukin (IL)-1ß pathway as a key driver of inflammation in PM. A critical membrane receptor for NLRP3 inflammasome activation is the ATP-activated P2 purinoceptor (P2R) P2X7. Thus, we hypothesized involvement of ATP and P2Rs in PM. The functional role of ATP was investigated in a mouse meningitis model using P2R antagonists. Brain expression of P2Rs was assessed by RT-PCR. ATP levels were determined in murine CSF and cell culture experiments. Treatment with the P2R antagonists suramin or brilliant blue G did not have any impact on disease course. This lack of effect might be attributed to meningitis-associated down-regulation of brain P2R expression and/or a drop of cerebrospinal fluid (CSF) ATP, as demonstrated by RT-PCR and ATP analyses. Supplemental cell culture experiments suggest that the reduction in CSF ATP is, at least partly, due to ATP hydrolysis by ectonucleotidases of neutrophils and macrophages. In conclusion, this study suggests that ATP-P2R signaling is only of minor or even no significance in PM. This may be explained by down-regulation of P2R expression and decreased CSF ATP levels.


Subject(s)
Meningitis, Pneumococcal/metabolism , Receptors, Purinergic/metabolism , Signal Transduction , Adenosine Triphosphate/cerebrospinal fluid , Animals , Antigens, CD/metabolism , Apyrase/metabolism , Bone Marrow Cells/drug effects , Bone Marrow Cells/metabolism , Brain/metabolism , Disease Progression , Extracellular Space/metabolism , Macrophage Activation/drug effects , Male , Meningitis, Pneumococcal/cerebrospinal fluid , Meningitis, Pneumococcal/microbiology , Meningitis, Pneumococcal/pathology , Mice, Inbred C57BL , Neutrophils/drug effects , Neutrophils/metabolism , Purinergic Antagonists/pharmacology , Signal Transduction/drug effects , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/physiology
19.
Mol Aspects Med ; 55: 9-19, 2017 06.
Article in English | MEDLINE | ID: mdl-28093236

ABSTRACT

Extracellular adenosine 5'-triphosphate (ATP) and adenosine molecules are intimately involved in immune responses. ATP is mostly a pro-inflammatory molecule and is released during hypoxic condition and by necrotic cells, as well as by activated immune cells and endothelial cells. However, under certain conditions, for instance at low concentrations or at prolonged exposure, ATP may also have anti-inflammatory properties. Extracellular ATP can activate both P2X and P2Y purinergic receptors. Extracellular ATP can be hydrolyzed into adenosine in a two-step enzymatic process involving the ectonucleotidases CD39 (ecto-apyrase) and CD73. These enzymes are expressed by many cell types, including endothelial cells and immune cells. The counterpart of ATP is adenosine, which is produced by breakdown of intra- or extracellular ATP. Adenosine has mainly anti-inflammatory effects by binding to the adenosine, or P1, receptors (A1, A2A, A2B, and A3). These receptors are also expressed in many cells, including immune cells. The final effect of ATP and adenosine in immune responses depends on the fine regulatory balance between the 2 molecules. In the present review, we will discuss the current knowledge on the role of these 2 molecules in the immune responses.


Subject(s)
Adenosine Triphosphate/metabolism , Immunity, Cellular/genetics , Inflammation/genetics , Receptors, Purinergic P1/genetics , 5'-Nucleotidase/genetics , Adenosine/genetics , Adenosine/immunology , Adenosine/metabolism , Adenosine Triphosphate/immunology , Antigens, CD/genetics , Apyrase/genetics , Endothelial Cells/immunology , Endothelial Cells/metabolism , Humans , Inflammation/immunology , Inflammation/pathology , Receptors, Purinergic P1/metabolism , Receptors, Purinergic P2X/genetics , Receptors, Purinergic P2Y/genetics
20.
SLAS Discov ; 22(1): 94-101, 2017 01.
Article in English | MEDLINE | ID: mdl-27821623

ABSTRACT

Apyrase is a calcium-activated enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to adenosine diphosphate (ADP), adenosine monophosphate (AMP), and Pi. It is currently used in studies involving cancer and platelet aggregation in humans, as well as herbicide resistance in plants. Inhibitors of apyrase are being investigated for their use to suppress tumors and combat herbicide resistance. Only a few inhibitors of apyrase have been reported, many of which were identified through automated screening using a 96-well plate format and colorimetric phosphate detection. However, these screens have had limitations, including large volumes, inconsistent reproducibility, high incidence of false hits, and lack of higher-throughput compatibility. A luciferin/luciferase-based detection system has been reported to examine potential inhibitors of apyrase; however, these reactions were performed in tubes with the assay completion in seconds, which necessitate the development of a high-throughput screening (HTS)-compatible format for screening. Therefore, a more cost-effective biochemical assay that improved the limitations of the previous assay formats using a commercially available luminescence-based detection system was developed. This new robust mix-and-read platform incorporates a low-volume luminescence-based protocol, formatted for use in 384-well microplates. This new format provides a simple and cost-effective method to screen for apyrase inhibitors and will facilitate larger HTS efforts to identify potent inhibitors of apyrase.


Subject(s)
Apyrase/metabolism , High-Throughput Screening Assays/methods , Luminescence , Drug Evaluation, Preclinical , Enzyme Inhibitors/analysis , Enzyme Inhibitors/pharmacology , Enzyme Stability , Kinetics
SELECTION OF CITATIONS
SEARCH DETAIL